Synthesis of new benzo[f]chromene-based heterocycles targeting anti-proliferative activity

Abu El-Azm, Fatma; El-Shahawi, Manal M.; Elgubbi, Amna S.; H. M. F. Madkour;

Abstract


Abstract: In this article β-enaminonitrile 1 undergoes intramolecular cyclocondensation reaction under acidic conditions to generate novel chromeno[2,3-b]azet-9-one derivative 2 in good yield. Ring expansion of the four membered ring of the azet-2(1H)-one derivative 2 to six and/or seven membered rings was achieved via reaction of compound 2 with different nitrogen nucleophiles. A new series of benzochromeneone, benzochromenopyrimidine, and benzo[f]coumarin derivatives were prepared via reaction of β-enaminonitrile 1 with different C-electrophiles. The structures of the products have been affirmed on the basis of analytical and spectral data. The anti-proliferative activity of the newly synthesized compounds against two human epithelial cell lines; liver (HepG2) and breast (MCF-7) in addition to normal fibroblasts (WI-38) was investigated. Derivatives 4 and 10 had significant and selective anti-proliferative activity against liver and breast cancer cell lines without harming normal fibroblasts. Graphic abstract: [Figure not available: see fulltext.].


Other data

Title Synthesis of new benzo[f]chromene-based heterocycles targeting anti-proliferative activity
Authors Abu El-Azm, Fatma ; El-Shahawi, Manal M.; Elgubbi, Amna S.; H. M. F. Madkour 
Keywords Anti-proliferative activity;Benzo[f]chromene;Benzo[f]chromeneone;Benzo[f]chromeno[2,3-d]pyrimidines;Benzo[f]coumarin;Chromeno[2,3-b]azet-9-one;Intramolecular cyclocondensation
Issue Date 1-May-2021
Publisher SPRINGER
Journal Journal of the Iranian Chemical Society 
Volume 18
Start page 1081
End page 1092
ISSN 1735-207X
DOI 10.1007/s13738-020-02092-w
Scopus ID 2-s2.0-85094140696
Web of science ID WOS:000584922600001

Attached Files

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 5 in scopus


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.